Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $1.84 million. The enterprise value is -$12.58 million.
Important Dates
The last earnings date was Thursday, November 12, 2026, after market close.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 823,772 shares outstanding. The number of shares has increased by 592.59% in one year.
| Current Share Class | 823,772 |
| Shares Outstanding | 823,772 |
| Shares Change (YoY) | +592.59% |
| Shares Change (QoQ) | +244.69% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 7.16% |
| Float | 774,898 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| Forward PS | 0.19 |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.47, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.47 |
| Quick Ratio | 3.95 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.37% and return on invested capital (ROIC) is -13.71%.
| Return on Equity (ROE) | -23.37% |
| Return on Assets (ROA) | -11.40% |
| Return on Invested Capital (ROIC) | -13.71% |
| Return on Capital Employed (ROCE) | -20.50% |
| Weighted Average Cost of Capital (WACC) | 9.41% |
| Revenue Per Employee | $707,438 |
| Profits Per Employee | -$123,456 |
| Employee Count | 50 |
| Asset Turnover | 1.08 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, SBFM has paid $344,836 in taxes.
| Income Tax | 344,836 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.21% in the last 52 weeks. The beta is 1.52, so SBFM's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -99.21% |
| 50-Day Moving Average | 8.07 |
| 200-Day Moving Average | 90.77 |
| Relative Strength Index (RSI) | 26.22 |
| Average Volume (20 Days) | 105,728 |
Short Selling Information
The latest short interest is 176,303, so 21.40% of the outstanding shares have been sold short.
| Short Interest | 176,303 |
| Short Previous Month | 840,899 |
| Short % of Shares Out | 21.40% |
| Short % of Float | 22.75% |
| Short Ratio (days to cover) | 0.23 |
Income Statement
In the last 12 months, SBFM had revenue of $35.37 million and -$6.17 million in losses. Loss per share was -$51.24.
| Revenue | 35.37M |
| Gross Profit | 10.74M |
| Operating Income | -5.96M |
| Pretax Income | -5.83M |
| Net Income | -6.17M |
| EBITDA | -5.63M |
| EBIT | -5.96M |
| Loss Per Share | -$51.24 |
Full Income Statement Balance Sheet
The company has $15.04 million in cash and $627,565 in debt, with a net cash position of $14.41 million or $17.50 per share.
| Cash & Cash Equivalents | 15.04M |
| Total Debt | 627,565 |
| Net Cash | 14.41M |
| Net Cash Per Share | $17.50 |
| Equity (Book Value) | 28.64M |
| Book Value Per Share | 102.85 |
| Working Capital | 26.21M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$6.01 million and capital expenditures $1,039, giving a free cash flow of -$6.01 million.
| Operating Cash Flow | -6.01M |
| Capital Expenditures | 1,039 |
| Depreciation & Amortization | 328,113 |
| Net Borrowing | -75,536 |
| Free Cash Flow | -6.01M |
| FCF Per Share | -$7.29 |
Full Cash Flow Statement Margins
Gross margin is 30.36%, with operating and profit margins of -16.84% and -17.45%.
| Gross Margin | 30.36% |
| Operating Margin | -16.84% |
| Pretax Margin | -16.48% |
| Profit Margin | -17.45% |
| EBITDA Margin | -15.91% |
| EBIT Margin | -16.84% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -592.59% |
| Shareholder Yield | -592.59% |
| Earnings Yield | -2,297.72% |
| FCF Yield | -327.05% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 26, 2026. It was a reverse split with a ratio of 1:20.
| Last Split Date | Oct 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
SBFM has an Altman Z-Score of -1.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.24 |
| Piotroski F-Score | 2 |